Menu
GeneBe

6-32027332-G-C

Variant summary

Our verdict is Likely benign. Variant got -5 ACMG points: 1P and 6B. PP2BP4_ModerateBS2

The NM_001002029.4(C4B):c.2689G>C(p.Val897Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. 12/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000097 ( 2 hom., cov: 4)
Exomes 𝑓: 0.000017 ( 7 hom. )
Failed GnomAD Quality Control

Consequence

C4B
NM_001002029.4 missense

Scores

5
12

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 2.61
Variant links:
Genes affected
C4B (HGNC:1324): (complement C4B (Chido/Rodgers blood group)) This gene encodes the basic form of complement factor 4, and together with the C4A gene, is part of the classical activation pathway. The protein is expressed as a single chain precursor which is proteolytically cleaved into a trimer of alpha, beta, and gamma chains prior to secretion. The trimer provides a surface for interaction between the antigen-antibody complex and other complement components. The alpha chain may be cleaved to release C4 anaphylatoxin, a mediator of local inflammation. Deficiency of this protein is associated with systemic lupus erythematosus. This gene localizes to the major histocompatibility complex (MHC) class III region on chromosome 6. Varying haplotypes of this gene cluster exist, such that individuals may have 1, 2, or 3 copies of this gene. In addition, this gene exists as a long form and a short form due to the presence or absence of a 6.4 kb endogenous HERV-K retrovirus in intron 9. [provided by RefSeq, May 2020]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -5 ACMG points.

PP2
Missense variant where missense usually causes diseases, C4B
BP4
Computational evidence support a benign effect (MetaRNN=0.1712833).
BS2
High Homozygotes in GnomAdExome at 3 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
C4BNM_001002029.4 linkuse as main transcriptc.2689G>C p.Val897Leu missense_variant 21/41 ENST00000435363.7

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
C4BENST00000435363.7 linkuse as main transcriptc.2689G>C p.Val897Leu missense_variant 21/411 NM_001002029.4 P1

Frequencies

GnomAD3 genomes
AF:
0.00
AC:
4
AN:
41274
Hom.:
2
Cov.:
4
FAILED QC
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000145
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000672
AC:
6
AN:
89294
Hom.:
3
AF XY:
0.0000410
AC XY:
2
AN XY:
48834
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000123
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.0000166
AC:
14
AN:
842226
Hom.:
7
Cov.:
14
AF XY:
0.0000142
AC XY:
6
AN XY:
423092
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000215
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.0000969
AC:
4
AN:
41274
Hom.:
2
Cov.:
4
AF XY:
0.000103
AC XY:
2
AN XY:
19332
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000145
Gnomad4 OTH
AF:
0.00
ExAC
AF:
0.0000339
AC:
2

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsDec 06, 2021The c.2689G>C (p.V897L) alteration is located in exon 21 (coding exon 21) of the C4B gene. This alteration results from a G to C substitution at nucleotide position 2689, causing the valine (V) at amino acid position 897 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.23
BayesDel_addAF
Benign
-0.085
T
BayesDel_noAF
Benign
-0.36
Cadd
Benign
22
Dann
Uncertain
1.0
DEOGEN2
Benign
0.051
T;T
Eigen
Benign
0.11
Eigen_PC
Benign
0.14
FATHMM_MKL
Uncertain
0.84
D
M_CAP
Benign
0.012
T
MetaRNN
Benign
0.17
T;T
MetaSVM
Benign
-0.93
T
MutationAssessor
Uncertain
2.6
M;.
MutationTaster
Benign
1.0
D;D
PROVEAN
Benign
-2.2
N;N
REVEL
Benign
0.12
Sift
Uncertain
0.0080
D;D
Sift4G
Uncertain
0.013
D;D
Polyphen
0.60
.;P
Vest4
0.41
MutPred
0.36
Loss of catalytic residue at V897 (P = 0.0674);Loss of catalytic residue at V897 (P = 0.0674);
MVP
0.29
ClinPred
0.37
T
GERP RS
3.6
Varity_R
0.51
gMVP
0.68

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.070
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs758340408; hg19: chr6-31995109; API